AltPep develops early disease-modifying treatments and detection tools for amyloid diseases.
Our lead programs aim to identify Alzheimer’s disease and Parkinson’s disease long before symptoms occur and then neutralize toxic soluble oligomers associated with these diseases.
The AltPep™ Platform is based on a collection of de novo designed synthetic peptides. The growing library is an arsenal that specifically targets the root causes of disease at the molecular level.
For the early detection and tracking of amyloid diseases using plasma and CSF.
These peptides target and neutralize the toxic soluble oligomers associated with amyloid diseases.